We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 02, 2020

Fast-Acting Insulin Aspart + Insulin Degludec Is Safe and Effective in Adults With T2D

Diabetes Care


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
Diabetes Care 2020 Mar 24;[EPub Ahead of Print], WS Lane, E Favaro, N Rathor, HC Jang, MIS Kjærsgaard, A Oviedo, L Rose, P Senior, G Sesti, A Soto Gonzalez, E Franek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading